ZYNE
$5.49
Zynerba Pharma CS
($.02)
(.36%)
ZYNE
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.20)
Revenue:  $0.00 Mil
Wednesday
Aug 11
6:45 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ZYNE reports earnings?
Beat
Meet
Miss

Where is ZYNE's stock price going from here?
Up
Flat
Down
Stock chart of ZYNE
Analysts
Summary of analysts' recommendations for ZYNE
Score
Grade
Pivots
Resistance
$5.78
$5.67
$5.58

$5.46

Support
$5.37
$5.26
$5.17
Tweet
Growth
Description
Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on developing and commercializing proprietary synthetic cannabinoid therapeutics formulated for transdermal delivery. Its product candidates which are in clinical trial stage include ZYN002 and ZYN001 synthetic transdermal cannabinoid therapeutics for indications including refractory epilepsy, Fragile X syndrome, osteoarthritis, fibromyalgia and peripheral neuropathic pain. Zynerba Pharmaceuticals, Inc. is headquartered in Devon, Pennsylvania.